AKT1 and malignant colon neoplasm: Examining downstream protein targets and pathways of Rictor-mTORC2 revealed that VTD reduces phosphorylation of Ser473 of AKT, negatively controls the population of colon cancer stem cells, slows angiogenesis, and increases both intrinsic and extrinsic apoptosis pathways.